- Apple is gearing up for a transformative investment in its Health app.
- This includes designing a separate AI agent that will address users health needs.
- The company is setting up a health campus to train the AI model.
- US stock indices crater on Monday as hinted 20% tariffs are expected to be universal in scope.
The US stock market sold off immediately upon opening on Monday, but Apple (AAPL) stock was largely unfazed. At the time of writing, Apple shares were up 0.2% a half hour into the morning session, while the indices shed weight much more extensively. Apple’s relative immunity to the market downturn is a result of announcing new investments in the health tech space.
The NASDAQ Composite tripped more than 2% lower, while the S&P 500 gave up 1.4%. The Dow Jones Industrial Average (DJIA) was once again the best-performing major index, losing a less pronounced 0.6%.
The reason for the flight was…again…more news on the tariff front. The Wall Street Journal has reported that the Trump administration is considering imposing 20% global tariffs on all foreign countries. On Sunday, US President Donald Trump walked back claims that the tariffs to be unveiled at Wednesday’s so-called Liberation Day event will apply to all nations, not just the smaller 15-20 that officials had been telling reporters previously.
Japan has been readying its own reciprocal tariffs on US goods after Trump imposed tariffs on foreign-made autos last week. Additionally, Trump said he is mulling 25% to 50% tariffs on all countries who buy oil from Russia since that nation’s leader, Vladimir Putin, has proven less amenable to Trump’s calls for a ceasefire deal with Ukraine.
Apple stock news
Bloomberg reports that Apple is preparing to launch an AI doctor project and that CEO Tim Cook has told employees that Apple’s greatest societal legacy will come via healthcare.
Apple Project Mulberry will feature a revamp of the company’s Health app for iPhone that includes an AI doctor assistant to provide insights, keep tabs on personal health data, and answer customers’ health-related questions. The details are somewhat sparse, but the full delivery of these features might be some way off.
The article says that Apple has been working on a noninvasive glucose monitor product for 15 years that works in conjunction with the Apple Watch. However, its projects to monitor hypertension and blood oxygen via the Apple Watch have faced several obstacles, including patent fights.
The Cupertino, California-based company has hired physicians to train its AI doctor feature. These include specialists in nutrition, cardiology, mental health, physical therapy and sleep. This project, tentatively called Health+, is being set up in the San Francisco region with its own headquarters.
In other news, Apple says its iPad Pro using the in-house M5 chip will enter production in the latter half of this year.
Apple stock forecast
Apple stock seems to be bouncing off recent lows that hit $208.42 on March 13. A break and close back above $218.23 will reduce investors' blood pressure as that is the 23.6% Fibonacci Retracement level. The 38.2% Fibo comes at $224.30.
However, the 50-day Simple Moving Average (SMA) looks likely to meet its 200-day counterpart soon enough near $230, so traders will get worried if that blue line falls below the purple. If it does so, that would result in a Death Cross pattern that is typically, broadly bearish.
Folks are really counting on the historical support at $196 holding the downtrend in place, but the market overall is at the mercy of Trump's tariff policy. Only Wednesday's Liberation Day will know what the future holds.
AAPL daily stock chart
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks

EUR/USD retreats from fresh multi-year highs, holds above 1.1000
EUR/USD neared 1.1150 in the European session on Thursday, shedding roughly 100 pips afterwards. The Euro holds on to solid gains amid broad US Dollar weakness, after US President Trump unveiled aggressive tariffs on the "Liberation Day." Markets await mid-tier US data releases.

GBP/USD surges to multi-month tops near 1.3200 ahead of US data
GBP/USD paused its rally after briefly surpassing the 1.3200 mark, yet holds on to most of its intraday gains. The US Dollar plunged to a fresh YTD low amid worries about a tariff-driven US economic slowdown, lifting Fed rate cut bets and weighing on the Greenback. The focus now remains on the US data for further impetus.

Gold retreats below $3,100 from all-time peak
Gold price extends its steady intraday pullback from the all-time peak touched this Thursday, and pierces the $3,100 mark in the European session. Bullish traders opt to take some profits off the table and lighten their bets around the commodity amid slightly overbought conditions.

SOL is the winner as Solana chain turns into battleground for meme coin launchpad and DEX
Solana (SOL) gains nearly 2% in the last 24 hours and trades at 118.28 at the time of writing on Thursday. A Decentralized Exchange (DEX) and a meme coin launchpad built on the Solana blockchain have waged a war for users and compete for the trade volume on the chain.

Trump’s “Liberation Day” tariffs on the way
United States (US) President Donald Trump’s self-styled “Liberation Day” has finally arrived. After four straight failures to kick off Donald Trump’s “day one” tariffs that were supposed to be implemented when President Trump assumed office 72 days ago, Trump’s team is slated to finally unveil a sweeping, lopsided package of “reciprocal” tariffs.

The Best brokers to trade EUR/USD
SPONSORED Discover the top brokers for trading EUR/USD in 2025. Our list features brokers with competitive spreads, fast execution, and powerful platforms. Whether you're a beginner or an expert, find the right partner to navigate the dynamic Forex market.